These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7096514)

  • 1. Multichannel diode array UV-visible spectrophotometer as detector in screening for unknown butoprozine metabolites in dog bile by high-performance liquid chromatography.
    Overzet F; Ghijsen RT; Drenth BF; De Zeeuw RA
    J Chromatogr; 1982 May; 240(1):190-5. PubMed ID: 7096514
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra- and inter-species comparisons of biliary metabolic profiles of butoprozine by high performance liquid chromatography.
    Overzet F; de Zeeuw RA
    Xenobiotica; 1985 Jan; 15(1):1-10. PubMed ID: 3984379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatography in the elucidation of the metabolic fate of butoprozine: screening for unknown metabolites in the rat.
    Drenth BF; de Zeeuw RA
    J Chromatogr; 1980 Apr; 191():109-14. PubMed ID: 7380960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-line diode array UV-visible spectrometry in screening for drugs and drug metabolites by high-performance liquid chromatography.
    Overzet F; Rurak A; van der Voet H; Drenth BF; Ghijsen RT; de Zeeuw RA
    J Chromatogr; 1983 Sep; 267(2):329-45. PubMed ID: 6630371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic isolation and fast atom bombardment mass spectrometric identification of Di-N-desethylamiodarone, a new metabolite of amiodarone in the dog.
    Latini R; Reginato R; Burlingame AL; Kates RE
    Biomed Mass Spectrom; 1984 Sep; 11(9):466-71. PubMed ID: 6509156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for impurities in butoprozine.
    Drenth BF; Jagersma T; Wormeester AJ; de Zeeuw RA
    Pharm Weekbl Sci; 1983 Aug; 5(4):149-52. PubMed ID: 6622208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone: individualizing dosage with serum concentrations.
    Rotmensch HH; Swanson BN; Greenspon AJ; Shoshani D; Greenspan AM
    Pacing Clin Electrophysiol; 1983 Nov; 6(6):1327-35. PubMed ID: 6196742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of amiodarone metabolites in human bile by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Deng P; You T; Chen X; Yuan T; Huang H; Zhong D
    Drug Metab Dispos; 2011 Jun; 39(6):1058-69. PubMed ID: 21398391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of amiodarone metabolites and impurities using liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
    Myung SW; Chang YJ; Min HK; Kim DH; Kim M; Kang TK; Yoo EA; Sohn YT; Yim YH
    Rapid Commun Mass Spectrom; 2000; 14(21):2046-54. PubMed ID: 11085417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the clinical pharmacokinetics of amiodarone.
    Paton DM; Webster DR; Neutze JM
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):41-9. PubMed ID: 6371407
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
    Kannan R; Miller S; Singh BN
    Drug Metab Dispos; 1985; 13(6):646-50. PubMed ID: 2867865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection.
    Bolderman RW; Hermans JJ; Maessen JG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(18-19):1727-31. PubMed ID: 19427276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of butoprozine on isolated heart preparations. Comparison with amiodarone and verapamil.
    Néliat G; Moreau M; Ducouret P; Gargouïl YM
    Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):220-36. PubMed ID: 6978694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute bioavailability of amiodarone in normal subjects.
    Pourbaix S; Berger Y; Desager JP; Pacco M; Harvengt C
    Clin Pharmacol Ther; 1985 Feb; 37(2):118-23. PubMed ID: 3967454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial disposition of amiodarone in the dog.
    Latini R; Connolly SJ; Kates RE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-line screening for drug metabolites by high-performance liquid chromatography with a diode array UV detector.
    Zech K; Huber R; Elgass H
    J Chromatogr; 1983 Dec; 282():161-7. PubMed ID: 6674313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy.
    Marchiset D; Bruno R; Djiane P; Cano JP; Benichou M; Serradimigni A
    Biopharm Drug Dispos; 1985; 6(2):209-15. PubMed ID: 4005397
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiodarone and reperfusion ventricular fibrillation.
    Ayoub CM; Sfeir PM; El-Khatib MF
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):207. PubMed ID: 20188593
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of butoprozine on ionic currents in frog atrial and ferret ventricular fibres. Comparison with amiodarone and verapamil.
    Néliat G; Ducouret P; Moreau M; Gargouïl YM
    Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):237-55. PubMed ID: 6280628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological properties of butoprozine studied by multiple intracardiac recordings on the anaesthetized dog.
    Sassine A; Fajuri A; Hirsch JL; de Claviere M; Masse C; Puech P
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):249-59. PubMed ID: 6838284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.